New York, February 23, 2018: The global antidiabetics market was valued at USD 41,305.7 million in 2013 and is expected to grow at a CAGR of more than 9.5% during the forecast period.

    Global Antidiabetics Market is anticipated to cross USD 80.0 Billion by 2022 growing at a CAGR of more than 9.5 % in the given forecast period.

    The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Sanofi-Aventis, Eli Lilly, Oramed Pharmaceuticals, Boehringer Ingelheim, Merck & Co. Inc., Bristol-Myers Squibb, Novo Nordisk, Halozyme Therapeutics, Pfizer and Takeda Pharmaceuticals. Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.

    You Can Find Full Report @:

    The Antidiabetics Market has been segmented as below:

    By Types of Insulin

    • Rapid Acting
    • Long Acting
    • Premixed
    • Premixed Analog
    • Short Acting
    • Intermediate Acting

    By Product

    • Biguanides
    • Thiazolodinediones
    • GLP-agonists
    • Sulphonylureas
    • DPP-4 inhibitors
    • SGLT-2
    • Alpha-glucosidase Inhibitors
    • Meglitinides

    By Geography

    • North America
    • Europe
    • Asia-Pacific
    • Rest of the World (ROW)

    The global antidiabetics market is segmented based on its product which includes thiazolodinediones, glp-agonists, sulphonylureas, dpp-4 inhibitors, sglt-2, alpha-glucosidase inhibitors, biguanides and meglitinides. The insulin is segmented as rapid acting, long acting, premixed, premixed analog, short acting and intermediate acting. The market segments in terms of geographical regions include North America, Europe, Asia-Pacific and Rest of the World (ROW).

    This report provides: 

    1) An overview of the global market for antidiabetics and related technologies.

    2) Analyses of global market trends, with data from 2013, estimates for 2014 and 2015, and projections of compound annual growth rates (CAGRs) through 2022.

    3) Identifications of new market opportunities and targeted promotional plans for acetic acid market.

    4) Discussion of research and development, and the demand for new products and new applications.

    5) Comprehensive company profiles of major players in the industry.

    North America hold the largest share in antidiabetics market as it holds highest rate of obesity in the world, which is one of the major reason for cause of diabetics.

    Ask Sample Report:


    Table of Contents

    2. Executive Summary
    3. Antidiabetics Industry
    4. Antidiabetics Product
    5. Antidiabetics Regional
    6. Competitive Landscape

    5.1  Sanofi Aventis

    5.1.1 Company Overview

    5.2 Takeda Pharmaceuticals

    5.3 Eli Lilly

    5.4 Oramed Pharmaceuticals Inc.

    5.5 Merck & Co. Inc.

    5.6 Novo Nordisk

    5.7 Bristol-Myers Squibb

    5.8 Halozyme Therapeutics

    5.9 Pfizer

    1. Methodology and Scope


    Media Contact

    Company Name: Market Research Engine

    Contact Person: John Bay


    Phone: +1-855-984-1862

    Country: United States